E. Graft

The absorption of low‐dose methotrexate in patients with inflammatory bowel disease

M. Averbuch, M. Tishler, M. Moshkowitz, 1996, Alimentary pharmacology & therapeutics.

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial).

U. Goldbourt, S. Behar, E. Kaplinsky, 1993, The American journal of cardiology.